Navigation Links
Para 12 Whole Blood Hematology Control, Three-part Differential

ProductsPara 12 Whole Blood Hematology Control, Three-part Differential
Company Streck
Item Para 12 Whole Blood Hematology Control, Three-part Differential
Features 
Description Para 12 is a three-part differential control assayed for all parameters on the Coulter S Series, STKR, J Series, T Series, AcT/AcT diff/AcT diff2, MD Series and ONYX Series; Abbott CELL-DYN 1400, 1500, 1600, 1700, and 1800; Danam Datacell18, Datacell 18MS/18MS Plus, Datacell 16CP and Excell 16; Infolab I-1800, I-1800MS/MS PLUS and I-1600; the ABX Micros 60, and the Bayer Celltek M. Varying levels of lymphocytes, mononuclear cells, and granulocytes are available at the low abnormal, normal and high abnormal levels. Para 12 has 110-day closed-vial stability. The open-vial stability is 14 days. Para 12 is available in a 2.5ml vial or a 4.5ml pierceable cap vial for instruments that have single closed-vial sampling or continuous closed-vial auto-sampling capability.
Info Streck
Customer Service: (800) 228-6090
Web site: http://www.streck.com/default.asp

Related medicine products :

1. Series 590 Low Cost Whole Blood Aggregometers
2. ACCUTEST Mononucleosis Whole Blood Test
3. ACCUTEST H. pylori Test (Whole Blood)
4. SST-1 Whole-field Scotopic Sensitivity Tester
5. Liquichek Whole Blood Volatiles Control
6. Lyphochek Whole Blood Control
7. Lyphochek Whole Blood Metals Control
8. Model 700 Whole Blood/Optical Lumi-Aggregometer
9. Glass Whole Blood Tube with K3EDTA
10. Whole Body Hypothermia System
11. Malaria (P. Falciparum) Whole Blood Strip / Cassette
...
...
...
The Lineage acetabular system with ceramic liners uses sophisticated manufacturing methods and materials to minimize wear debris generation....
Medicine Products:
(Date:4/25/2017)... KY (PRWEB) , ... April 25, 2017 , ... ... announce they have signed an agreement to be the preferred physical therapy provider ... injuries and returning them to Derby City CrossFit as quickly and effectively as ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... compare student test score performance for the 2015-16 school year across Wisconsin’s public ... programs. Though it highlights important patterns in student test score performance, the report’s ...
(Date:4/25/2017)... ... 25, 2017 , ... As pharmaceutical companies are held to ... process innovation in drug formulation and manufacturing. CoreRx offers its clients more ... in support of their development and manufacturing goals. , The company was ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the ... or chronic problems, I focus on preventative care with all my patients to alleviate possible ... questions, always feel free to contact my office and my trained staff will assist you ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... April 19, 2017  IRIDEX Corporation (Nasdaq: ... results for the first quarter 2017 after the close ... management team will host a corresponding conference call beginning ... Investors interested in listening to the conference call ... callers or (703) 326-3030 for international callers, using conference ...
(Date:4/19/2017)... , April 19, 2017  Sorrento Therapeutics, Inc. ... clinical-stage biopharmaceutical company developing new treatments for cancer ... closing of its previously announced underwritten public offering ... a public offering price of $2.00 per share, ... offering expenses payable by Sorrento.  The net proceeds ...
Breaking Medicine Technology: